Inspira to Publish HYLA Clinical Results in Q4 2024
Ticker: IINNW · Form: 6-K · Filed: Aug 28, 2024 · CIK: 1837493
| Field | Detail |
|---|---|
| Company | Inspira Technologies Oxy B.H.N. LTD (IINNW) |
| Form Type | 6-K |
| Filed Date | Aug 28, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: clinical-results, medical-device, filing-update
TL;DR
Inspira dropping HYLA clinical results Q4 '24. Big news for their tech.
AI Summary
Inspira Technologies Oxy B.H.N. Ltd. announced on August 28, 2024, that it will publish clinical results for its HYLA device in the fourth quarter of 2024. This update was provided in a Form 6-K filing with the SEC.
Why It Matters
The release of clinical results for the HYLA device is a key milestone that could impact the company's future product development and market positioning in the medical technology sector.
Risk Assessment
Risk Level: medium — The company's reliance on the successful development and market acceptance of its HYLA device presents a significant risk.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- HYLA (product) — Device for which clinical results will be published
FAQ
When will Inspira Technologies publish the clinical results for its HYLA device?
Inspira Technologies plans to publish the HYLA clinical results in the fourth quarter of 2024.
What type of filing is this report?
This is a Form 6-K report, which is a report of a foreign private issuer.
What is the primary business of Inspira Technologies Oxy B.H.N. Ltd. based on SIC code?
Based on the Standard Industrial Classification (SIC) code 3841, the company is involved in Surgical & Medical Instruments & Apparatus.
Where is Inspira Technologies Oxy B.H.N. Ltd. located?
The company's principal executive office is located at 2 Ha-Tidhar St., Ra'anana 4366504, Israel.
What is the filing date of this report?
The filing date of this report is August 28, 2024.
Filing Stats: 304 words · 1 min read · ~1 pages · Grade level 8.9 · Accepted 2024-08-28 09:05:33
Filing Documents
- ea0212643-6k_inspira.htm (6-K) — 12KB
- ea021264301ex99-1_inspira.htm (EX-99.1) — 13KB
- 0001213900-24-073140.txt ( ) — 26KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: August 28, 2024 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2